SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000902664-17-000955
Filing Date
2017-02-09
Accepted
2017-02-09 16:40:20
Documents
1

Document Format Files

Seq Description Document Type Size
1 p17-0338sc13ga.htm SC 13G/A 60685
  Complete submission text file 0000902664-17-000955.txt   62221
Mailing Address 9393 TOWNE CENTRE DRIVE SUITE 200 SAN DIEGO CA 92121
Business Address 9393 TOWNE CENTRE DRIVE SUITE 200 SAN DIEGO CA 92121 858-332-3410
Mirati Therapeutics, Inc. (Subject) CIK: 0001576263 (see all company filings)

IRS No.: 462693615 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-87670 | Film No.: 17588116
SIC: 2834 Pharmaceutical Preparations

Mailing Address 120 WEST 45TH STREET SUITE 2802 NEW YORK NY 10036
Business Address 120 WEST 45TH STREET SUITE 2802 NEW YORK NY 10036 212-937-4975
venBio Select Advisor LLC (Filed by) CIK: 0001633313 (see all company filings)

IRS No.: 271007403 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A